Unpublished and misreported studies make it difficult to determine the true value of a treatment. Peter Doshi and colleagues call for sponsors and investigators of abandoned studies to publish (or republish) and propose a system for independent publishing if sponsors fail to respond.
A call to publish—or be published
A call to action, publishing trials, credibly
Call for restorative authors and participating journals
When it comes to illness, men and women really do react differently
” Medical research conducted over the past 40 years has focused almost exclusively on male patients, say Italian researchers… Women suffering cardiac arrest suffer abdominal pain and nausea, NOT the standard warning signs of chest pain radiating down left arm… Women’s non-specific symptoms mean inadequate treatment is given… ”
As one of the world’s highest production volume chemicals, Bisphenol-A is incredibly common in food and drinks packaging, as well as in other places you probably wouldn’t expect, like receipts.
A study in Analytical and Bioanalytical Chemistry found that of 13 thermal printing papers (the type often used for receipts) analyzed, 11 contained BPA.v Holding the paper for just 5 seconds was enough to transfer BPA onto a person’s skin, and the amount of BPA transferred increased by about 10 times if the fingers were wet or greasy.
The FDA didn’t ban DES and today recognizes the DES tragedy but refuses to apologize to the victims.
Pharmaceutical giant Eli Lilly who manufactured DES in the US has never accepted responsibility nor apologized for the DES tragedy.
Should DES victims learn to accept an apology they will never get? … Nine people commented so far, what do you think?
As national class actions duel in Canada, there is no better time to look to Europe
Quite technical but very interesting article which helps understand some of the EU legislation that authorizes collective actions. DES is cited as an example for collective settlements in The Netherlands.
Jeanne Conry, MD, PhD, sworn in as ACOG’s 64th president
DES Action USA recently commented: ” We always say the DES story must be told so it doesn’t happen again. The new president of the American College of Obstetricians and Gynecologists agrees – and specifically mentioned DES in her inaugural speech. Progress!!!! ”
Stop censoring photos of men and women who have undergone mastectomies
Congratulations on the victory of the petition asking Facebook to stop censoring photos of men and women who have undergone mastectomies! “We want the world to know breast cancer is not a pink ribbon – it is traumatic, it is life-changing, and it urgently needs a cure.” says Scorchy Barrington who launched the petition signed by more than 21,000 people.
Endocrine Disruptors permanent effect on Obesity through at least three Generations
Girls between 9 and 12 years of age with higher-than-average levels of bisphenol-A (BPA) in their urine had double the risk of being obese than girls with lower levels of BPA, according to a Kaiser Permanente study published today … Read more, ScienceDaily, June 12, 2013.
Bisphenol-A (BPA) is a potential endocrine disruptor impacting metabolic processes and increasing the risk of obesity. To determine whether urine BPA level is associated with overweight/obesity in school-age children, we examined 1,326 students in grades 4–12 from three schools (one elementary, one middle, and one high school) in Shanghai. More than 98% of eligible students participated. Total urine BPA concentration was measured and anthropometric measures were taken by trained research staff. Information on risk factors for childhood obesity was collected for potential confounders. Age- and gender-specific weight greater than 90th percentile of the underlying population was the outcome measure. After adjustment for potential confounders, a higher urine BPA level (≥2 µg/L), at the level corresponding to the median urine BPA level in the U.S. population, was associated with more than two-fold increased risk of having weight >90th percentile among girls aged 9–12 (adjusted odds ratio (aOR) = 2.32, 95% confidence interval: 1.15–4.65). The association showed a dose-response relationship with increasing urine BPA level associated with further increased risk of overweight (p = 0.006 for trend test). Other anthropometric measures of obesity showed similar results. The same association was not observed among boys. This gender difference of BPA effect was consistent with findings from experimental studies and previous epidemiological studies. Our study suggests that BPA could be a potential new environmental obesogen. Widespread exposure to BPA in the human population may also be contributing to the worldwide obesity epidemic.